Kudo Masashi, Gotohda Naoto, Sugimoto Motokazu, Kobayashi Shin, Kobayashi Tatsushi
Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwa-no-ha, Kashiwa, 277-8577, Chiba, Japan.
Department of Diagnostic Radiology, National Cancer Center Hospital East, Kashiwa, Japan.
Langenbecks Arch Surg. 2025 Jun 6;410(1):177. doi: 10.1007/s00423-025-03764-y.
Significant advances have been made in image-based determinations of future remnant liver function, in attempts to better predict post-hepatectomy liver failure (PHLF). We have reported time-associated liver functional assessments using magnetic resonance imaging with liver-to-spleen signal intensity ratio increasing rate (LSRi) and LSRi of the future remnant liver region (LSRi-rem) to predict PHLF. This study aimed to investigate the predictability of PHLF by a preoperative liver function assessment index that combined LSRi-rem and future remnant liver volume (FRLV).
Participants comprised 333 patients who underwent EOB-MRI for the diagnosis of liver tumor before major hepatectomy between 2009 and 2024. LSRi-rem was evaluated by three-dimensional volumetric analysis, and the volume adjusted LSRi-rem (vaLSRi-rem) was calculated using the following formula: LSRi-rem × (FRLV / whole-liver volume). The vaLSRi-rem and clinical variables were then analyzed to assess the risk of PHLF.
In patients with vaLSRi-rem < 0.147, right hepatectomy, operation time ≥ 400 min, and estimated blood loss ≥ 1495 mL were associated with clinically relevant PHLF (P < 0.05 each) in multivariable analysis. Multivariable analysis showed the highest odds ratio (OR) for vaLSRi-rem (OR 9.12; P < 0.01). Of the 333 patients, 114 (34%) underwent portal vein embolization before major hepatectomy. The OR of vaLSRi-rem from multivariable analysis in this patient cohort was particularly high (OR 21.04; P < 0.01).
Strong associations were identified between vaLSRi-rem and clinically relevant PHLF after major hepatectomy, particularly among portal vein embolization patients.
在基于图像确定未来残余肝功能方面已取得重大进展,旨在更好地预测肝切除术后肝功能衰竭(PHLF)。我们曾报道使用磁共振成像进行与时间相关的肝功能评估,通过肝脾信号强度比增加率(LSRi)以及未来残余肝区的LSRi(LSRi-rem)来预测PHLF。本研究旨在探究一种术前肝功能评估指标对PHLF的预测能力,该指标结合了LSRi-rem和未来残余肝体积(FRLV)。
研究对象为2009年至2024年间在接受大肝切除术前因肝肿瘤诊断而接受EOB-MRI检查的333例患者。通过三维容积分析评估LSRi-rem,并使用以下公式计算体积校正后的LSRi-rem(vaLSRi-rem):LSRi-rem×(FRLV/全肝体积)。然后分析vaLSRi-rem和临床变量以评估PHLF的风险。
在多变量分析中,vaLSRi-rem<0.147的患者、接受右半肝切除术、手术时间≥400分钟以及估计失血量≥1495毫升与临床相关的PHLF相关(每项P<0.05)。多变量分析显示vaLSRi-rem的优势比(OR)最高(OR 9.12;P<0.01)。在333例患者中,114例(34%)在大肝切除术前接受了门静脉栓塞。该患者队列多变量分析中vaLSRi-rem的OR特别高(OR 21.04;P<0.01)。
在大肝切除术后,尤其是门静脉栓塞患者中,vaLSRi-rem与临床相关的PHLF之间存在密切关联。